The effect of adding pancreatin to standard otilinium bromide and simethicone treatment in type 2 diabetes mellitus patients with irritable bowel syndrome.
- 2024-10-21
- Observational · n = 121
- Scientific reports 14(1)
- Hulusi Can Karpuzcu
- Beril Turan Erdoğan
- Çağdaş Erdoğan
- PubMed: 39433866
- DOI: 10.1038/s41598-024-74694-w
- High evidence
- Rigorous Journal
- Clinical
After treatment, the triple therapy group demonstrated statistically significant improvements in VAS score (p < 0.001), IBS-SSS (p < 0.001), and IBS-QOL (p < 0.001) compared to the dual therapy group.
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes